Gout
From the Journals
Allopurinol extension trial backs treat-to-target approach in gout
The results alleviate fears of adverse events from heightened doses, especially in patients with impaired kidney function.
News
FDA approves once-daily treatment for hyperuricemia in gout
Duzallo is a fixed-dose combination of lesinurad 200 mg and allopurinol 300 mg and will also be available as lesinurad 200 mg plus allopurinol 200...
From the Journals
Musculoskeletal ultrasound training now offered in nearly all U.S. rheumatology fellowships
Rheumatology fellowship programs offering musculoskeletal ultrasound training grew from 60% in a 2013 survey to 94% in 2017.
From the Journals
For acute gout, corticosteroids look safer than NSAIDs
A meta-analysis of six randomized, controlled trials suggests equal efficacy, but patients taking corticosteroids had a lower frequency of...
Conference Coverage
Allopurinol and ventricular arrhythmias: Is there a link?
MADRID – The gout drug’s tie to fewer arrhythmias strengthened over time.
Conference Coverage
Trial supports naproxen over low-dose colchicine for acute gout
BIRMINGHAM, ENGLAND – Naproxen may be considered the first-choice treatment for patients with acute gout in primary care, based on results of the...
Feature
Compounding rules challenge practice norms
In a tighter regulatory environment, a routine part of rheumatology practice is called into question.
From the Journals
First treat-to-target gout trial supports allopurinol dose escalation
Gradually ramping up the dose of allopurinol to achieve target serum urate levels in gout patients who tolerate the drug is safe and effective,...
News
CDC: Greater activity limitations accompany rising arthritis prevalence
Physical activity and weight loss may help patients with arthritis retain a higher range of motion.
Conference Coverage
VIDEO: Urate lowering therapy improved kidney function
WASHINGTON – Urate lowering therapy improved kidney function in patients with chronic kidney disease.
Conference Coverage
Flare risk lower in early-gout patients treated with urate-lowering therapy
WASHINGTON – Lowering serum urate level and treating to target in patients with early gout achieved substantial reductions in gout flares,...